LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.06 | 27.76 | 747 | 360 | 2.0750 | 1.4366 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.76 | 27.76 | 13 | 401 | 0.0324 | -0.1787 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.76 | 27.76 | 810 | 401 | 2.0192 | 1.4001 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.76 | 27.76 | 781 | 401 | 1.9469 | 1.3775 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.46 | 27.76 | 9 | 438 | 0.0205 | -0.2464 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.46 | 27.76 | 848 | 438 | 1.9332 | 1.3601 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.46 | 27.76 | 830 | 438 | 1.8922 | 1.3474 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.17 | 27.76 | 17 | 489 | 0.0348 | -0.1117 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.17 | 27.76 | 906 | 489 | 1.8525 | 1.3212 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.17 | 27.76 | 893 | 489 | 1.8259 | 1.3132 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.87 | 27.76 | 17 | 604 | 0.0281 | -0.1044 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.87 | 27.76 | 935 | 604 | 1.5462 | 1.2060 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.87 | 27.76 | 932 | 604 | 1.5412 | 1.2044 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 15.58 | 27.76 | 17 | 685 | 0.0248 | -0.1006 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 15.58 | 27.76 | 939 | 685 | 1.3697 | 1.1407 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 15.58 | 27.76 | 1 | 685 | 0.0015 | -0.5125 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 15.58 | 27.76 | 953 | 685 | 1.3901 | 1.1476 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.28 | 27.76 | 13 | 838 | 0.0155 | -0.1430 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.28 | 27.76 | 949 | 838 | 1.1315 | 1.0509 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | G15 |